No abstract available
MeSH terms
-
Diabetes Mellitus, Type 2 / drug therapy*
-
Diabetes Mellitus, Type 2 / epidemiology
-
Exenatide
-
Glucagon-Like Peptide 1 / agonists
-
Glucagon-Like Peptide 1 / analogs & derivatives*
-
Glucagon-Like Peptide 1 / therapeutic use
-
Humans
-
Hypoglycemic Agents / therapeutic use*
-
Liraglutide
-
Multicenter Studies as Topic
-
Peptides / therapeutic use*
-
Randomized Controlled Trials as Topic
-
Safety
-
Treatment Outcome
-
Venoms / therapeutic use*
Substances
-
Hypoglycemic Agents
-
Peptides
-
Venoms
-
Liraglutide
-
Glucagon-Like Peptide 1
-
Exenatide